Barriers to Satisfactory Migraine Outcomes. What Have We Learned, Where Do We Stand?

Barriers to optimal migraine care have traditionally been divided into a number of categories: under‐recognition and underconsultation by migraine sufferers; underdiagnosis and undertreatment by health care professionals; lack of follow‐up and treatment optimization. These “traditional” barriers hav...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Headache 2009-07, Vol.49 (7), p.1028-1041
Hauptverfasser: Bigal, Marcelo, Krymchantowski, Abouch Valenty, Lipton, Richard B.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1041
container_issue 7
container_start_page 1028
container_title Headache
container_volume 49
creator Bigal, Marcelo
Krymchantowski, Abouch Valenty
Lipton, Richard B.
description Barriers to optimal migraine care have traditionally been divided into a number of categories: under‐recognition and underconsultation by migraine sufferers; underdiagnosis and undertreatment by health care professionals; lack of follow‐up and treatment optimization. These “traditional” barriers have been recognized and addressed for at least 15 years. Epidemiologic studies suggest that consultation, diagnosis, and treatment rates for migraine have improved although many migraine sufferers still do not get optimal treatment. Herein, we revisit the problem, review areas of progress, and expand the discussion of barriers to migraine care. We hypothesize that the subjective nature of pain and difficulty in communicating it contributes to clinical and societal barriers to care. We then revisit some of the traditional barriers to care, contrasting rates of recognition, diagnosis, and treatment over the past 15 years. We follow by addressing new barriers to migraine care that have emerged as a function of the knowledge gained in this process.
doi_str_mv 10.1111/j.1526-4610.2009.01410.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67467569</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67467569</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4300-457078e58244697cd779891d30c30f8e7130cf65dfea71b0a910cf4e64022b9d3</originalsourceid><addsrcrecordid>eNqNkU9vEzEQxS0EomnhKyBfQBy6Yfx_9wIqbWmQElopRTlazu4sOGx2i72B5NvjJVG4Ab54PP7N85MfIZTBmKX1ZjVmiutM6tTgAMUYmEzl9hEZHS8ekxEAM1luZH5CTmNcAYDUhX5KTlgh8oIJMyL3710IHkOkfUfnrvexdmXfhR2d-S_B-Rbp7aYvuzXGMV18dT2duB9IF0in6EKL1XnqYkB61Q3Nee_a6t0z8qR2TcTnh_2MfP5wfX85yaa3Nx8vL6ZZKQVAJpUBk6PKuUy-TFkZUyRblYBSQJ2jYamqtapqdIYtwRUsnSVqCZwvi0qckVd73YfQfd9g7O3axxKbxrXYbaLVRmqjdPFPkCdBUNwk8PVfQaY0MFAKIKH5Hi1DF2PA2j4Ev3ZhZxnYISW7skMYdgjDDinZ3ynZbRp9cXhls1xj9WfwEEsCXh4AF0vX1MG1pY9HjjMjuFaDh7d77qdvcPffBuzk-uJqKJNAthfwscftUcCFb-nzhFF28enG8gLu7mazuZ2LX4kjuQA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1560105500</pqid></control><display><type>article</type><title>Barriers to Satisfactory Migraine Outcomes. What Have We Learned, Where Do We Stand?</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Bigal, Marcelo ; Krymchantowski, Abouch Valenty ; Lipton, Richard B.</creator><creatorcontrib>Bigal, Marcelo ; Krymchantowski, Abouch Valenty ; Lipton, Richard B.</creatorcontrib><description>Barriers to optimal migraine care have traditionally been divided into a number of categories: under‐recognition and underconsultation by migraine sufferers; underdiagnosis and undertreatment by health care professionals; lack of follow‐up and treatment optimization. These “traditional” barriers have been recognized and addressed for at least 15 years. Epidemiologic studies suggest that consultation, diagnosis, and treatment rates for migraine have improved although many migraine sufferers still do not get optimal treatment. Herein, we revisit the problem, review areas of progress, and expand the discussion of barriers to migraine care. We hypothesize that the subjective nature of pain and difficulty in communicating it contributes to clinical and societal barriers to care. We then revisit some of the traditional barriers to care, contrasting rates of recognition, diagnosis, and treatment over the past 15 years. We follow by addressing new barriers to migraine care that have emerged as a function of the knowledge gained in this process.</description><identifier>ISSN: 0017-8748</identifier><identifier>EISSN: 1526-4610</identifier><identifier>DOI: 10.1111/j.1526-4610.2009.01410.x</identifier><identifier>PMID: 19389137</identifier><identifier>CODEN: HEADAE</identifier><language>eng</language><publisher>Malden, USA: Blackwell Publishing Inc</publisher><subject>barriers to care ; Biological and medical sciences ; Cardiovascular system ; Communication Barriers ; Humans ; Medical sciences ; Migraine Disorders - psychology ; Migraine Disorders - therapy ; migraine outcomes ; Neurology ; Pharmacology. Drug treatments ; Physician-Patient Relations ; Referral and Consultation ; satisfaction ; Surveys and Questionnaires ; Treatment Outcome ; Vascular diseases and vascular malformations of the nervous system ; Vasodilator agents. Cerebral vasodilators</subject><ispartof>Headache, 2009-07, Vol.49 (7), p.1028-1041</ispartof><rights>2009 the Authors. Journal compilation © 2009 American Headache Society</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4300-457078e58244697cd779891d30c30f8e7130cf65dfea71b0a910cf4e64022b9d3</citedby><cites>FETCH-LOGICAL-c4300-457078e58244697cd779891d30c30f8e7130cf65dfea71b0a910cf4e64022b9d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1526-4610.2009.01410.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1526-4610.2009.01410.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21732650$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19389137$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bigal, Marcelo</creatorcontrib><creatorcontrib>Krymchantowski, Abouch Valenty</creatorcontrib><creatorcontrib>Lipton, Richard B.</creatorcontrib><title>Barriers to Satisfactory Migraine Outcomes. What Have We Learned, Where Do We Stand?</title><title>Headache</title><addtitle>Headache</addtitle><description>Barriers to optimal migraine care have traditionally been divided into a number of categories: under‐recognition and underconsultation by migraine sufferers; underdiagnosis and undertreatment by health care professionals; lack of follow‐up and treatment optimization. These “traditional” barriers have been recognized and addressed for at least 15 years. Epidemiologic studies suggest that consultation, diagnosis, and treatment rates for migraine have improved although many migraine sufferers still do not get optimal treatment. Herein, we revisit the problem, review areas of progress, and expand the discussion of barriers to migraine care. We hypothesize that the subjective nature of pain and difficulty in communicating it contributes to clinical and societal barriers to care. We then revisit some of the traditional barriers to care, contrasting rates of recognition, diagnosis, and treatment over the past 15 years. We follow by addressing new barriers to migraine care that have emerged as a function of the knowledge gained in this process.</description><subject>barriers to care</subject><subject>Biological and medical sciences</subject><subject>Cardiovascular system</subject><subject>Communication Barriers</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Migraine Disorders - psychology</subject><subject>Migraine Disorders - therapy</subject><subject>migraine outcomes</subject><subject>Neurology</subject><subject>Pharmacology. Drug treatments</subject><subject>Physician-Patient Relations</subject><subject>Referral and Consultation</subject><subject>satisfaction</subject><subject>Surveys and Questionnaires</subject><subject>Treatment Outcome</subject><subject>Vascular diseases and vascular malformations of the nervous system</subject><subject>Vasodilator agents. Cerebral vasodilators</subject><issn>0017-8748</issn><issn>1526-4610</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU9vEzEQxS0EomnhKyBfQBy6Yfx_9wIqbWmQElopRTlazu4sOGx2i72B5NvjJVG4Ab54PP7N85MfIZTBmKX1ZjVmiutM6tTgAMUYmEzl9hEZHS8ekxEAM1luZH5CTmNcAYDUhX5KTlgh8oIJMyL3710IHkOkfUfnrvexdmXfhR2d-S_B-Rbp7aYvuzXGMV18dT2duB9IF0in6EKL1XnqYkB61Q3Nee_a6t0z8qR2TcTnh_2MfP5wfX85yaa3Nx8vL6ZZKQVAJpUBk6PKuUy-TFkZUyRblYBSQJ2jYamqtapqdIYtwRUsnSVqCZwvi0qckVd73YfQfd9g7O3axxKbxrXYbaLVRmqjdPFPkCdBUNwk8PVfQaY0MFAKIKH5Hi1DF2PA2j4Ev3ZhZxnYISW7skMYdgjDDinZ3ynZbRp9cXhls1xj9WfwEEsCXh4AF0vX1MG1pY9HjjMjuFaDh7d77qdvcPffBuzk-uJqKJNAthfwscftUcCFb-nzhFF28enG8gLu7mazuZ2LX4kjuQA</recordid><startdate>200907</startdate><enddate>200907</enddate><creator>Bigal, Marcelo</creator><creator>Krymchantowski, Abouch Valenty</creator><creator>Lipton, Richard B.</creator><general>Blackwell Publishing Inc</general><general>Wiley-Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>200907</creationdate><title>Barriers to Satisfactory Migraine Outcomes. What Have We Learned, Where Do We Stand?</title><author>Bigal, Marcelo ; Krymchantowski, Abouch Valenty ; Lipton, Richard B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4300-457078e58244697cd779891d30c30f8e7130cf65dfea71b0a910cf4e64022b9d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>barriers to care</topic><topic>Biological and medical sciences</topic><topic>Cardiovascular system</topic><topic>Communication Barriers</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Migraine Disorders - psychology</topic><topic>Migraine Disorders - therapy</topic><topic>migraine outcomes</topic><topic>Neurology</topic><topic>Pharmacology. Drug treatments</topic><topic>Physician-Patient Relations</topic><topic>Referral and Consultation</topic><topic>satisfaction</topic><topic>Surveys and Questionnaires</topic><topic>Treatment Outcome</topic><topic>Vascular diseases and vascular malformations of the nervous system</topic><topic>Vasodilator agents. Cerebral vasodilators</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bigal, Marcelo</creatorcontrib><creatorcontrib>Krymchantowski, Abouch Valenty</creatorcontrib><creatorcontrib>Lipton, Richard B.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Headache</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bigal, Marcelo</au><au>Krymchantowski, Abouch Valenty</au><au>Lipton, Richard B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Barriers to Satisfactory Migraine Outcomes. What Have We Learned, Where Do We Stand?</atitle><jtitle>Headache</jtitle><addtitle>Headache</addtitle><date>2009-07</date><risdate>2009</risdate><volume>49</volume><issue>7</issue><spage>1028</spage><epage>1041</epage><pages>1028-1041</pages><issn>0017-8748</issn><eissn>1526-4610</eissn><coden>HEADAE</coden><abstract>Barriers to optimal migraine care have traditionally been divided into a number of categories: under‐recognition and underconsultation by migraine sufferers; underdiagnosis and undertreatment by health care professionals; lack of follow‐up and treatment optimization. These “traditional” barriers have been recognized and addressed for at least 15 years. Epidemiologic studies suggest that consultation, diagnosis, and treatment rates for migraine have improved although many migraine sufferers still do not get optimal treatment. Herein, we revisit the problem, review areas of progress, and expand the discussion of barriers to migraine care. We hypothesize that the subjective nature of pain and difficulty in communicating it contributes to clinical and societal barriers to care. We then revisit some of the traditional barriers to care, contrasting rates of recognition, diagnosis, and treatment over the past 15 years. We follow by addressing new barriers to migraine care that have emerged as a function of the knowledge gained in this process.</abstract><cop>Malden, USA</cop><pub>Blackwell Publishing Inc</pub><pmid>19389137</pmid><doi>10.1111/j.1526-4610.2009.01410.x</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0017-8748
ispartof Headache, 2009-07, Vol.49 (7), p.1028-1041
issn 0017-8748
1526-4610
language eng
recordid cdi_proquest_miscellaneous_67467569
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects barriers to care
Biological and medical sciences
Cardiovascular system
Communication Barriers
Humans
Medical sciences
Migraine Disorders - psychology
Migraine Disorders - therapy
migraine outcomes
Neurology
Pharmacology. Drug treatments
Physician-Patient Relations
Referral and Consultation
satisfaction
Surveys and Questionnaires
Treatment Outcome
Vascular diseases and vascular malformations of the nervous system
Vasodilator agents. Cerebral vasodilators
title Barriers to Satisfactory Migraine Outcomes. What Have We Learned, Where Do We Stand?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T02%3A29%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Barriers%20to%20Satisfactory%20Migraine%20Outcomes.%20What%20Have%20We%20Learned,%20Where%20Do%20We%20Stand?&rft.jtitle=Headache&rft.au=Bigal,%20Marcelo&rft.date=2009-07&rft.volume=49&rft.issue=7&rft.spage=1028&rft.epage=1041&rft.pages=1028-1041&rft.issn=0017-8748&rft.eissn=1526-4610&rft.coden=HEADAE&rft_id=info:doi/10.1111/j.1526-4610.2009.01410.x&rft_dat=%3Cproquest_cross%3E67467569%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1560105500&rft_id=info:pmid/19389137&rfr_iscdi=true